US FDA stepping up enforcement of

美国FDA加强对制药公司广告规定的执法,向企业发送信函

By Michael Erman, Jeff Mason and Ahmed Aboulenein

记者:迈克尔·厄曼、杰夫·梅森、艾哈迈德·阿布勒奈因

September 10, 20257:37 AM GMT+8Updated 1 hour ago

2025年9月10日格林威治标准时间+8上午7:37,1小时前更新

The U.S. Food and Drug Administration will send out around 100 cease-and-desist enforcement notices and thousands of letters warning pharmaceutical companies that direct-to-consumer ads must comply with regulations that are already on the books, senior administration officials said on Tuesday.

⋯ 继续阅读请开通会员 ⋯